The Saxon program provides military academy students with an opportunity to work alongside OMRF senior scientists.
Oklahoma Medical Research Foundation
OMRF receives new grants to study blood clotting, ovarian cancer
The National Institutes of Health grants total nearly $2.1 million.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
The best Father’s Day gift: A healthy heart
Heart disease is the leading cause of death for men in the U.S., killing one in every four males.
OMRF seeks healthy minority participants for one-time blood sample donation
The foundation hopes to recruit up to 2,000 healthy individuals.
OMRF researcher named to American Cancer Society Council
Jones has served the ACS for many years, both as a grant reviewer and speaker on the society’s behalf.
